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The objective of this study was the investigation of a potential influence of artichoke leaf extract (ALE) on 
the cell physiology and gene expression of phase I/II enzymes of human liver cells HepG2 and investigation 
on potential cell protective effects against ethanol-induced cell toxicity against HepG2 cells. Cell biological 
assays under in vitro conditions using HepG2 liver cells and investigation of mitochondrial activity (MTT 
test), proliferation assay (BrdU incorporation ELISA), LDH as toxicity marker, gene expression analysis 
by RT-PCR and enzyme activity of glutationtransferase. Artichocke extract, containing 27% caffeoylquinic 
acids and 7% flavonoids induced mitochondrial activity, proliferation and total protein content under in vitro 
conditions in human liver cells HepG2. These effects could not be correlated to the well-known artichoke 
secondary compounds cynarin, caffeic acid, chlorogenic acid, luteolin and luteolin-7-O-glucoside. The 
flavones luteolin and luteolin-7-O-glucoside had inhibitory effects at 100 mg/mL level on HepG2 cells, 
with luteolin being a significant stronger inhibitor compared to the respective glucoside. Artichoke leaf 
extract had minor stimulating effect on gene expression of CYP1A2, while CYP3A4, GGT, GPX2, GSR 
and GST were slightly inhibited. GST inhibition under in vitro conditions was also shown by quantification 
of GST enzyme activity. Induction of gene expression of CYP1A2 was shown to be supraadditive after 
simultaneous application of ethanol plus artichoke extract. Artichoke leaf extract exhibited cell protective 
effects against ethanol-induced toxicity within cotreatment under in vitro conditions. Also H
2
O
2
 damage 
was significantly inhibited by simultaneous artichoke incubation. Pre- and posttreatments did not exert 
protective effects. DMSO-induced toxicity was significantly reduced by pre-, post- and cotreatment with 
artichoke extract and especially with luteolin-7-O-glucoside, indicating a direct interaction with the toxifying 
agent and an induction of repair mechanisms.
Uniterms: Cynara scolymus L. Asteraceae. Artichoke. Liver cells. Cell proliferation. Gene expression.
O objetivo deste estudo foi a investigação de uma potente influência do extrato das folhas da alcachofra 
(ALE) na fisiologia celular e na expressão gênica de enzimas de fase I/II de células hepáticas humanas 
HepG2 e investigação no potencial efeito protetor celular em células HepG2 contra toxicidade celular 
induzida por etanol. Ensaios biológicos de células em condições in vitro usando células de fígado HepG2 
e investigação da atividade mitocondrial (teste MTT), ensaio de proliferação, LDH como marcador de 
toxicidade, análise de expressão gênica por RT-PCR e atividade da enzima glutationa transferase. O 
extrato da alcachofra, contendo 27% de ácidos cafeoilquínico e 7% de flavonóides, induzem a atividade 
mitocondrial, proliferação e o teor de proteína total em condições in vitro em células hepáticas humanas 
HepG2. Estes efeitos não podem ser correlacionados aos compostos secundários conhecidos da alcachofra, 
cinarina, ácido cafeico, ácido clorogênico, luteolina e luteolin-7-O-glicosídeo. As flavonas luteolina e 
luteolin-7-O-glicosídeo possuem efeitos inibitórios em nível de 100 mg/mL em células HepG2, com a 
luteonina sendo uma inibidora significativamente mais forte comparada com o respectivo glicosídeo. O 
extrato das folhas de alcachofra possui um efeito mínimo da estimulação na expressão gênica de CYP1A2, 
enquanto CYP3A4, GGT, GPX2, GSR e GST foram sutilmente inibidos. A inibição de GST em condições 
in vitro também foi mostrada pela quantificação da atividade da enzima GST. Indução da expressão gênica 
de CYP1A2 mostrou-se supraaditiva após aplicação simultânea do etanol mais o extrato de alcachofra. O 
extrato das folhas de alcachofra exibiu efeitos protetores celulares frente à toxicidade induzida por etanol 
em co-tratamento em condições in vitro. Além disso, danos por H2O2 foram significativamente inibidos 
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pela incubação simultânea do extrato de alcachofra. Pré e pós-tratamento não exerceram efeitos protetores. 
Toxicidade induzida por DMSO foi significativamente reduzida por pré, pós e co-tratamento com extrato 
de alcachofra e especialmente com luteína-7-O-glicosídeo, indicando uma interação direta com o agente 
toxicante e a indução dos mecanismos de reparo.
Unitermos: Cynara scolymus L. Asteraceae. Alcachofra. Células hepáticas. Proliferação cellular. 
Expressão gênica.
INTRODUCTION
Cynara scolymus L. is an herbal medicinal product 
widely used in functional foods and phytotherapeutics 
for digestive complaints, adjuvant treatment of moderate 
hyperlipidaemia and hepato-biliary disorders in traditional 
European medicine. For review of established clinical use 
see (ESCOP Monograph, 2003). Traditionally, hepatostimu-
lating effects are described; for review see (Brand, 1992). 
The herbal material is phytochemically charac-
terized by caffeoylquinic acids, e.g. chlorogenic acid 
and 1,5-dicaffeoylquinic acid (cynarin), flavonoids (e.g. 
luteolin-7-O-glucoside and 7-O-rutinoside) and bitter 
tasting sesquiterpene lactones (e.g. cynaropicrin). Various 
aliphatic acids and caffeic acid derivatives are described. 
Concerning the mode of action for treatment of 
hypercholesterinaemia (Brand, 1990) the reduction of 
elevated serum cholesterol levels by artichoke is due to 
an inhibition of incorporation of acetate into the non-
saponifiable lipid fraction and thus will reduce cholesterol 
biosynthesis (Gebhard, 1995; Gebhard, 1996). As assessed 
by a recent Cochrane review [5] the clinical effects publi-
shed unto now indicate a clear tendency towards lower 
serum cholesterol during artichoke therapy. Other benefits 
as lipid-lowering efficacy are reported, the evidence ho-
wever is not compelling. 
Other traditional uses of artichoke leaf extract are 
digestive complaints and hepatobiliary disturbances (for 
review see EScop Monograph, 2003). These indications 
are due to an increased secretion of bilary substances into 
bile canali (Matuschowski et al. 1997; Gebhard, 2001), 
leading to a choleretic effect (Matuschowski et al., 2005). 
Clinical data on the use of artichoke on this topic are pro-
mising and are reviewed in the above mentioned ESCOP 
monograph. Other traditional uses of artichoke leaf extract 
are hepatoprotective (Adzet et al., 1987; Preziosi, 1962, 
Wojcicki, 1978; Gebhard 1997) and liver regenerating 
effects (Maros et al., 1968).
Because literature does not answer the question on 
the cellular mode of action concerning hepatoactivity the 
aim of the following study was the in vitro investigation 
of artichoke extracts and isolated compounds on cell 
physiology of human liver cells and to evaluate potential 
hepatoprotective effects against different exogenous noxes 
on physiological and gene expression level.
MATERIALS AND METHODS
General
Standardized artichoke extract was obtained from 
Casellamed, Köln, Germany and was derived from a com-
mercialized extract use for Hepar®SL forte by extraction 
with aliphatic alcohols (Wittemer et al, 2005). This extract 
contained 27.5% caffeoylquinic acids with 10.3% speci-
fied as 3-caffeoylquinic acids. The sum of flavonoids in 
the extract was 7.1% with 5.8% of luteolin-7-O-glucosid. 
Cynarin, chlorogenic acid, caffeic acid, luteolin and 
luteolin-7-O-glucosid were obtained by Casellamed AG 
with purity > 95%. If not stated otherwise, biological as-
says were performed in 3 independent assays in replicates.
Testing on human liver cell line
HepG2 (ATCCC HB-8065) cell line, clon H20, 
capable to express phase I and II metabolizing enzymes 
under standard cell culture conditions, was obtained from 
Prof. Mersch-Sundermann, University of Giessen, Germa-
ny, and was cultured as described previously (Dauer et al., 
2003; Hofmann et al., 2007). Cells were routinely grown 
in low glucose (1 g/L) Dulbecco`s Modified Eagle`s Me-
dium (DMEM) with L-glutamine and 25 mM Hepes (PAA, 
Cölbe, Germany) supplemented with 15 % (v/v) heat-
inactivated fetal calf serum and gentamycin (30 µg/mL) 
in a humidified atmosphere at 37+/-0.5°C, 5% CO
2
 
(Incubator Binder AG, Germany).  The medium was 
changed every 3-5 days. Test-substances were dissolved at 
1 mg/mL in HepG2-medium (if necessary under addition 
of DMSO as cosolvent, respective control solutions in the 
same way) and filtered through 0.2 µm cellulose-acetate 
(Iwaki Glass, Tokyo, Japan).
Cell assays
Incubation with test compounds occurred over 48 
hours: cells were seeded into 96-well cell plates (Greiner, 
Frickenhausen, Germany) at 1 x 104 cells/well. After 
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24 h, the medium was removed and cells were exposed 
to 100 and 10 µg/mL of test compounds for 48 h. Cell 
viability was quantified using the MTT-test according to 
Mosmann, 1983). Cell proliferation was quantified by 
BrdU-Incorporation ELISA [18]. Extracytosolic LDH 
(Porstmann et al., 1985) was quantified by cytotoxicity 
assay (Roche Diagnostics, Mannheim, Germany). For 
gene expression analysis, cells were incubated together 
with test compounds for 24 hours. Total RNA was iso-
lated with Perfect RNA Eukaryotic Mini Kit (Eppendorf, 
Hamburg) according to the instructions of the manufac-
turer. The amount of total RNA was estimated by optical 
density at 260 nm. Equal amounts of RNA were used for 
reverse transcriptase polymerase chain reaction (RT-PCR) 
done with TaqMan® Reverse Transcription Reagents® 
(Applied Biosystems, Darmstadt). Real-Time-PCR was 
carried out using the TaqMan® Universal PCR Master 
Mix and specific TaqMan® gene expression assays (from 
Applied Biosystems, Darmstadt, Germany):
 
For GST no distinct isoforms were screened but 
the protein coding gene type GST SCLo6A1 from the 
HGNC 23613 primary source with a validated RefSeq 
status from human gene identification number Hs.388874 
from chromosome No. 5 Matuschowsky et al., 1997). 
Glyceraldehyd-3-phosphate dehydrogenase was used as 
the internal reference. Data were quantified by the 7300 
Real-time PCR System RQ Study software (Applied Bio-
systems, Darmstadt). Gene expression was monitored in 
3 independent assays.
Protein biochemistry
Protein isolation: Adherent cells were washed two 
times with ice cold water, followed by treatment with lyses 
buffer (NaPP buffer, 50 mM, pH 6.8, 5% SDS, 40 mM 
DTT, 5mM EDTA, 5 mM EGTA, 15% glycerine, 0.1% 
Triton®X-100). Cells were harvested, transferred into a 
tube and lysed by sonication for 3 x 10 sec. Supernatant 
was used after centrifugation (12.000xg) for protein de-
termination according to (Lowry et al., 1951). GST was 
determined using the GST determination of Novagen (San 
Diego, U.S.A) (Suzuki et al., 2003).
RESULTS
An artichocke leaf extract (ALE) containing 27% 
caffeoylquinic acids and 7% flavonoids (Wittemer et 
al, 2005) signifi cantly increased the mitochondrial de-
hydrogenase activities of human liver HepG2 after 48 h 
incubation time at a 100 mg/mL level, while lower doses 
were ineffective (Fig. 1A). This was confirmed by the 
results of proliferation test: ALE significantly increased 
proliferation rate at doses of 100 mg/mL to about 130% 
proliferation, and at 10 mg/mL to 120%; lower doses were 
ineffective (Fig. 1B). Additionally a significant increase in 
protein content in treated HepG2 cells was measured: ALE 
at 100 mg/mL significantly induced the protein content of 
the cells to about 130% (data not shown), reflecting the 
increase in cell number and energy turn over.  
genes Assay ID
GPX Hs00702173_s1
CYP1A2 Hs00167927_m1
CYP3A4 Hs00604506_m1
GGT1 Hs00359124_g1
GSR Hs00167317_m1
GST Hs00542846_m1
GAPDH Hs99999905_m1
FIGURE 1 - Influence of  artichoke leaf extract (ALE) at 1, 10 
and 100 mg/mL level on mitochondrial dehydrogenase activity 
(A) and mitotic cell proliferation (B) of HepG2 cells after 48 
hours incubation. Mitochondrial activity determined by MTT 
test, proliferation determination by BrdU incorporation ELISA. 
The bars represent standard errors SD from 3 independent 
experiments with n = 10 replicates each with *p < 0.05, 
**p < 0.01 compared to the untreated control group.
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No necrotic and apoptotic cytotoxicity of ALE was 
observed within the test range of 1 to 100 mg/mL as measured 
by LDH determination and inspection on apoptotic bodies. 
To investigate the influence of isolated artichoke 
compounds on HepG2 cells reference compounds luteolin, 
luteolin-7-O-glucosid, caffeic acid, chlorogenic acid and 
cynarin were tested at 100, 10 and 1 mg/mL level. Within 
MTT assay cynarin, chlorogenic acid and caffeic acid did 
not exhibit any significant effect. Luteolin and luteolin-7-
O-glucosid at 100 mg/mL (3.5 x 10-7 resp. 2.3 x 10-7 mol/L) 
significantly decreased mitochondrial activity (Fig. 2A), 
related to the calculation of absolute amounts of 100 mg/mL 
of both compounds. Also when the measured data were 
normalized to equimolar concentrations (3.5 x 10-7 mol/L 
Luteolin with 84 % inhibition,  3.5 x 10-7 mol/L,  luteolin-
7-O-glucoside with 54 % inhibition) significantly higher 
inhibition of mitochondrial activity was obvious for lute-
olin compared to the respective glycoside. This was also 
reflected within the respective proliferation assays (Fig. 
2B). The inhibitory effect of the flavone-glucosid was 
significantly lower than that of the free aglycon luteolin.
The mRNA expression of different phase I and II en-
zymes of HepG2 cells was determined by quantitative RT-
PCR after a 24 h incubation time of cells with and without 
ALE in serum-free media. Gene expression was monitored 
in 3 independent assays for glutathione-S-transferase GST, 
glutathionperoxidase GPX, glutathionreductase GSR, g-
glutamyltransferase GGT1 and the cytochrome P450 iso-
forms CYP1A2 and CYP3A4. These CYPs were selected 
because CYP3A4 is the main hepatic cytochrom (about 
30%) beside CYP1A2 (about 10 to 12%). Measured test 
values were related to the expression of the endogenous 
control glycerol-3-phosphate dehydrogenase (GAPDH). 
mRNA expression for CYP1A2 was slightly increased in 
the presence of artichoke extract ALE (100 mg/mL) to 1.76 
+/- 2.4. Because of the high variability this effect is as-
sessed not to be significant. Significant inhibition of gene 
expression by ALE was seen for CYP3A4 (0.23 +/- 0.39), 
for GGT1 (0.59+/- 0.21), for GPX2 (0.50 +/- 0.30), for 
GSR (0.72 +/- 0.23) and GST (0.22 +/-0.28).
The inhibition of glutathione-S-transferase GST 
gene expression was confirmed by determination of the 
respective enzyme activity. Therefore HepG2 cells were 
incubated with ALE (100, 10 mg/mL) for 48 h. Total pro-
tein was isolated from cell lysate and GST activity was de-
termined after conjugation of 1-chloro-2,4-dinitrobenzene 
CDNB to endogenous GST. GST activity was calculated 
relative to the total cell protein content against a GST 
calibration curve in ALE-treated cells and untreated con-
trol. As shown in Fig. 3 ALE  inhibited GST activity in a 
dose-dependent manner.
Summarizing at this point, artichoke extract is as-
sessed to have stimulating activity on the proliferation and 
the energy turn-over of liver cells, accompanied by effects 
on metabolising enzymes.
In order to investigate if artichoke extract has also 
anti-toxic effects against exogenous chemicals, ALE was 
tested as cytoprotective activity against the toxifying 
effects of ethanol (marker for unspecific enzyme toxicity), 
hydrogenperoxide (oxidative toxicity) and dimethylsulfo-
FIGURE 2 - Influence of luteolin and luteolin-7-O-glucoside 
at 1, 10, 100 mg/mL on mitochondrial dehydrogenase activity 
(A) and mitotic cell proliferation (B) of HepG2 cells after 48 
hours of incubation. Mitochondrial activity was determined by 
MTT test, proliferation was determined by BrdU incorporation 
ELISA. The bars represent SD from independent assay with 
n = 10 replicates with *p < 0.05,  **p < 0.01 compared to the 
untreated control group.
FIGURE 3 - Concentration-dependent inhibition of glutathione-
S-transferase (GST) in HepG2 cells after 48 h treatment with 
ALE relative to the total protein concentration. The bars 
represent  SD with n = 10 replicates *p < 0.05.
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xid (necrotic toxicity). In a preliminary study the respec-
tive concentrations and incubation times were verified to 
induce a cell toxicity, equivalent to about 50% reduction of 
MTT activity.  Ethanol was used in the following studies at 
a 25 to 50 mM level, H
2
O
2
 at 1 to 10 mM, and DMSO at 3.5 
and 5% concentration over a 6 to 24 hours incubation time. 
As shown in Table I, cotreatment of HepG2 cells 
with ALE (100 mg/mL) and ethanol (25 and 50 mM) for 
48 hours showed a significant protective effect. Also at 
10 mg level the respective data showed (not significant) 
tendencies towards cytoprotective effects.
Also cotreatment of HepG2 cells with ALE 
(100 mg/mL) and H
2
O
2
 (1, 5, 10 mM) for 24 hours sho-
wed a significant protective effect against the low-dose 
hydrogen peroxide induced toxicity: while only minor 
antioxidative effects of ALE were seen against strong cell 
damage induced by 10 mM H
2
O
2, 
clear effects of ALE were 
observed against 5 mM H
2
O
2.  
 Coincubation of HepG2 cells with DMSO (3.5 and 
5%) and ALE for 48 hours (10, 100 mg/mL) indicated 
reduced DMSO-induced toxicity at the 100 mg/mL level, 
while lower doses did not protect from DMSO-mediated 
cell toxicity. 
Similar test systems, but with pre- and postincuba-
tion of cells with ethanol, H
2
O
2 
or DMSO prior or after 
an ALE-treatment, did not reduce the toxic effects of the 
chemicals towards HepG2 cells.  
In addition to these experiments with artichoke 
extract, a potential cytoprotective effect of the flavonole 
reference compounds luteolin and luteolin-7-O-glucoside 
was investigated against DMSO as exogenous stress fac-
tor. For that purpose one cell group, serving as a control, 
was treated with DMSO 10%. Proliferation behaviour of 
this group - with a significantly reduced vitality in contrast 
to an untreated control - was calculated as 100%. Coin-
cubation of two cell groups with luteolin + DMSO 10% 
resp. luteolin-7-O-glucoside + DMSO 10% indicated that 
the flavone-glycoside significantly protects cells against 
DMSO-related toxicity (Fig. 4).
For investigation of the cytoprotective effects of 
ALE against ethanol-induced cell damage the mRNA ex-
pression of different phase I and II liver enzymes was de-
termined after 3 different treatment cycles of HepG2 cells 
over a 24 h incubation time (pre-, post- and cotreatment 
FIGURE 4 - Proliferation (BrdU-ELISA) of HepG2 cells within 
48 h cotreatment with DMSO 10% and 100 mg/mL luteolin (0.35 
mM/mL) resp. luteolin-7-O-glucoside (0.22 mM/mL).*p < 0.05 
compared to the DMSO 10% control  group.
TABLE I - Influence of different pre-, post- and cotreatment regimes of ethanol, hydrogen peroxide and DMSO in combination 
with artichocke extract (ALE) on mitochondrial activity of HepG2 cells. Mitochondrial activity was determined by MTT test and 
measured values were related to the respective control groups (100%). **p < 0.01. ⇒: followed by treatment with compounds 
indicated
Type of treatment of HepG2 cells Mitochondrial Activity (%)
Ethanol 50 mM; 48 h ⇒  ALE 100 mg; 48 h 313 +/- 38% **
Ethanol 25 mM; 48 h ⇒  ALE 100 mg; 48 h 178 +/- 77% **
Ethanol 50 mM; 48 h ⇒  ALE  10 mg; 48 h 283 +/- 111% 
Ethanol 25mM; 48 h ⇒  ALE  10 mg; 48 h 168 +/- 60%
H
2
O
2  
10 mM; 24 h ⇒ ALE 100 µg; 24 h 116 +/- 2%
H
2
O
2  
5 mM; 24 h ⇒ ALE 100 µg; 24 h 263 +/- 92% **
H
2
O
2  
1 mM; 24 h ⇒ ALE 100 µg; 24 h 107 +/- 12%
DMSO 5%; 48 h ⇒ ALE 100 mg; 48 h 100 +/- 12 %
DMSO 5%; 48 h ⇒ ALE  10 mg; 48 h   97 +/- 7 %
DMSO 3.5%; 48 h ⇒ ALE 100 mg; 48 h 137 +/- 6 % **
DMSO 3.5%; 48 h ⇒ ALE  10 mg; 48 h 101 +/- 4 %
G. Löhr, A. Deters, A. Hensel206
of cells with ethanol 50 mM and ALE 100 mg/mL). Gene 
expression was monitored for GST, GPX, GSR, GGT1, 
CYP1A2 and CYP3A4 and all values were related to the 
expression of the endogenous control GAPDH. As shown 
in Table II ethanol 50 mM increased mRNA levels of 
CYP1A2 significantly. Pre- and posttreatment experiments 
with ALE revealed no big differences between the differ-
ent test groups. In contrast to that, a thirtyfold increase in 
CYP1A2 was observed when coincubation was performed 
with ethanol plus ALE for a 24 h incubation period, indi-
cating a strong influence of the artichoke-ethanol mixture 
on metabolic activity of the liver cells.
Significant influences of ethanol and/or ALE on 
expression of GST, GPX, GSR, GGT1 were not observed. 
CONCLUSIONS
Extracts of artichoke are widely used for its choleret-
ic and antihypercholesterinaemic effects. Within literature 
potential hepatoprotective effects are described, mainly us-
ing in vivo rat models (Gebhard, 1997). In vitro studies of 
hepatoprotective effects of artichoke extracts on cultured 
rat hepatocytes are shown against t-butylhydroperoxide-
induced peroxidation of membrane lipids (Gebhard, 1997). 
Additionally cyanarin and caffeic acid were shown to 
reduce the carbontetrachloride-induced leakage of liver 
enzymes glutamic oxaloacetic transaminase and glutamic 
pyruvic transaminase (Adzet et al., 1987).
These data correlate with our investigations, indica-
ting artichoke extract to have a direct effect on liver cells. 
Cell physiology of HepG2 cells is clearly up-regulated, 
with increased mitochondrial activity, leading to a higher 
energy status, inducing an increased protein synthesis and 
ending in a higher mitogenic activity. On the other side 
it is absolutely unclear which compounds from artichoke 
are responsible for these effects. In our investigations 
neither cynarin, chlorogenic acid or caffeic acid had any 
influence on the energy status of the cells. From that point 
of view artichoke extract specifications for preparations 
marketed with the indication “hepatoprotection” should 
not be standardized on these compounds. On the other side 
the flavones were shown to have strong inhibitory effects 
on liver cells with luteolin being a quite strong inductor 
of apoptosis by inhibition of topoisomerase II (Cantero et 
al., 2006). It seems interesting that luteolin-7-O-glucoside 
has significantly less toxic effects on HepG2 cells rather 
than the free aglycon luteolin, probably by a reduced 
absorption into the cells. For manufacture of commercial 
artichoke leaf extracts specifications therefore should 
focus on the amount of luteolin-glucoside beside that of 
the free aglycon.
Because the protein content of the cells is increased 
during incubation with artichoke extract it could be ar-
gued that also the metabolizing enzymes are upregulated 
unspecifically. This is clearly not the case when looking 
at the gene expression data of phase I and II enzymes 
expressed in HepG2 cells. Only one cytochrome mRNA, 
namely CYP1A2 is upregulated to a minor degree which is 
assessed to have no clinical relevance. All other enzymes 
monitored were slightly inhibited. This was also confirmed 
by biochemical determination of enzyme activity of GST 
which was significantly down-regulated by artichoke ex-
tract. If this enzyme inhibition has any clinical relevance 
this has to be investigated by in vivo studies in future.
Beside the direct effect of artichoke extract on 
HepG2 cells, pronounced cell protection by ALE was 
obvious. This was not only due to the known antioxi-
dative effects of artichoke which were obvious in our 
studies against hydrogen peroxide and in previous studies 
(Gebhard, 1997) against t-BHP. Cell protection of ALE 
can also be discussed on ethanol-induced cell damage over 
metabolic pathways as well as against necrotic membrane 
disturbance, induced by compounds as DMSO. In general 
direct interactions between toxifying agents and ALE can 
be claimed as shown by the respective cotreatment expe-
riments. On the other side also indirect effects are induced 
TABLE II - Influence of artichoke extract (ALE, 100 mg/mL) in pre-, post- and cotreatment experiments with ethanol (50 mM) on 
relative gene expression on cytochromes CYP1A2 and CYP3A4 by quantitative real time PCR (TaqMan® assay), normalized to 
the house keeping gene GAPDH and untreated controls. ⇒: followed by treatment with compounds indicated
Treatment of HepG2 cells CYP1A2 CYP3A4
Ethanol 50 mM; 1 h ⇒ ALE 100 mg; 23 h 3.3 1.0
Control experiment: Ethanol 50 mM; 1 h ⇒ Medium only; 23 h 3.0 2.5
ALE 100 mg; 23 h ⇒ Ethanol 50 mM; 1 h 7.1 1.7
Control experiment: Medium only; 23 h ⇒ Ethanol 50 mM; 1 h 6.2 1.0
Ethanol 50 mM; 24 h + ALE 100 mg; 24 h 29.8 3.9
Control experiment: Medium + ALE 100 mg; 24 h 1.8 0.7
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by artichoke extracts. The posttreatment experiments with 
ALE after damage with DMSO clearly confirmed the in-
duction of repair mechanisms. A prophylactic application 
of artichoke extract does not seem to have an effect. On the 
other side it has to be pointed out that the positive effects 
of ALE against EtOH-, H
2
O
2
- and DMSO-damaged liver 
cells is not due to a detoxificant effect but more due to 
an stimulation of metabolic capacity of the cells. Sum-
marizing artichoke leaf extract may have the potential to 
be used as hepatoprotective agent. Prospective research 
will identify those compounds, which are responsible for 
described effects. 
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